Altimmune to Participate at Two Upcoming Investor Conferences
GAITHERSBURG, Md., Nov. 22, 2022 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq:ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will participate at the following investor conferences:
Related news for (ALT)
- MoBot’s Stock Market Highlights – 09/22/25 10:00 AM
- Spider Silk & Crypto-Powered Rebrands Signal a New Investor Web
- Don’t Miss Out: MoBot’s Latest Stock Updates 09/11/25 07:00 PM
- Today’s Top Performers: MoBot’s Market Review 09/11/25 06:00 PM
- Today’s Top Performers: MoBot’s Market Review 09/11/25 04:00 PM